DrMark Morris
Reader in Molecular Oncology
Faculty of Science and Engineering
Orcid identifier0000-0002-0700-355X (opens in a new tab)
- Reader in Molecular OncologyFaculty of Science and Engineering
- 01902322574 (Work)
RESEARCH INTERESTS
My main research interest is the underlying genomic errors and molecular pathways that drive tumour development and metastasis; the principal goal of this work is to identify novel therapeutic targets for the treatment of tumours. I have a particular interest/expertise in renal, bone and brain cancers and metastatic breast cancer.
GRANTS
- GRANTMolecular Characterisation of the role of microRNAs (Rotha Abraham Bequest) (C8)1 Aug 2025 - 31 Aug 2026
- GRANTAdamantinoma BiomarkersBone Cancer Research Trust1 Mar 2021 - 31 Dec 2023
- GRANTBench Fees - RSF: Ivonne OlivaresInternal Bench Fees1 Feb 2017 - 31 Jul 2022
- GRANTDevelopment of Nano-Disulfiram to target pancreatic ductal cancer stem cellsPancreatic Cancer UK1 Jan 2017 - 1 Jan 2020
- GRANTDevelopment of AAV vectors to restore dystrophin variants to muscleThe French Muscular Dystrophy Association1 Jan 2014 - 1 Jan 2016
- GRANTDNA methylation in tumour progression to brain metastasisBrain Tumour North West Research Fund1 Jan 2013 - 1 Jan 2014People funded by this grant:
- Morris M
- GRANTPreclinical Studies of 5-aza-2'-deoxycytidine Treatment of Renal Cell Carcinoma Cell LinesCelgene1 Jan 2011 - 1 Jan 2012People funded by this grant:
- Morris M
- GRANTCRUK Renal Molecular Oncology Programme GrantCancer Research UK1 Jan 2006 - 1 Jan 2011People funded by this grant:
- Morris M